In this episode of Canada’s Economy, Explained, host Marwa Abdou sits down with Dr. Chad P. Bown, Reginald Jones Senior Fellow at the Peterson Institute for International Economics and former Chief Economist at the U.S. Department of State, to examine how new U.S. tariffs could impact Canada’s economy.Bown explains how Canada’s deep ties to U.S. supply chains leave it exposed to major cost increases, warning that tariffs could “double or triple” production expenses and hit smaller suppliers hardest. He cautions against retaliation, reminding policymakers that “tariffs also cause self-harm.”The conversation covers why automation limits the return of manufacturing jobs and why Canada’s efforts to diversify trade partners face steep challenges from geography and infrastructure barriers. Bown also shares cautious optimism. While Washington’s direction on trade is confusing even to insiders, he reassures Canadians that “you still have a lot of fans in Washington” and reminds listeners that democratic systems can correct poor policy over time.Listen to the full conversation to understand why careful, long-term thinking is key to protecting Canada’s economy. Chad Bown websiteTrade Talks PodcastCanada-US Trade Tracker
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare